CTNNB1 and neoplasm: Significant negative bias was observed against most Ctnnb1 mutations (except I35 mutations) in KrasG12D-rescued conditional transformants, with these mutations largely absent from tumours rescued 30 days after ENU treatment (Fig. 4d–f).